Richard E Uihlein insider trades

Open-market stock purchases and sales by Richard E Uihlein, Unknown at Galectin Therapeutics Inc, from SEC Form 4 filings since Dec 14, 2017.

Track record: 14% of 7 scored buys are up 5% or more since purchase, averaging -20%.

Recent trades

DateStockTradeValue
Jul 31, 2026GALT Galectin Therapeutics IncBought (not open market)$26,354B
Jul 31, 2026GALT Galectin Therapeutics IncBought (not open market)$3,038,537B
Jan 16, 2026GALT Galectin Therapeutics IncBought (not open market)$40K
Jan 16, 2026GALT Galectin Therapeutics IncBought (not open market)—

Companies traded

  • GALT Galectin Therapeutics Inc: 11 buys, last Jul 31, 2026

Get free alerts when Richard E Uihlein files a new trade →